Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1

被引:13
作者
Bae, Pan Kee
Kim, Jee Hyun
Kim, Hae Soo
Chung, In Kwon
Paik, Sang Gi
Lee, Chong-Kyo
机构
[1] KRICT, Pharmacol Res Ctr, Taejon 305600, South Korea
[2] Yonsei Univ, Dept Biol, Seoul 120749, South Korea
[3] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea
关键词
herpes simplex virus; thymidine kinase; TK-deficiency; drug-resistance; antiherpetic drug; nucleoside uptake; nucleoside anabolism;
D O I
10.1016/j.antiviral.2006.01.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of the thymidine(Thd) kinase(TK) of herpes simplex virus type I (HSV-1) on the intracellular uptake and anabolism of nucleosides has been investigated. To compare the differences between the TK-positive (TK+) and TK-deficient strains, acyclovir (ACV)-resistant strains were cloned from a cell culture and classified into 2 groups, viz. the TK-partial (TKP) and TK-negative (TK-). The cellular uptake of thymidine was highly dependent on the viral TK (vTK) activity. The TK+ strain showed the highest level of intracellular thymidine uptake, the TKP strain a moderate level, which varied from strain to strain, and the TK- and mock strains showed little uptake. The inhibition of viral replication by ACV, ganciclovir (GCV) and penciclovir (PCV) did not decrease the Thd uptake at all. On the contrary, a notable increase found to be induced by ACV. The influence of the vTK on the uptake of GCV or PCV was much greater than that of ACV. The metabolism was generally less dependent on the vTK activity than the influx. The influx and phosphorylation rates of GCV and PCV were dependent on the substrate specificity of the vTK. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 104
页数:12
相关论文
共 42 条
[1]  
[Anonymous], EFFECTIVE CLIN PRACT
[2]   Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy [J].
Bacon, TH ;
Levin, MJ ;
Leary, JJ ;
Sarisky, RT ;
Sutton, D .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :114-+
[3]   Nucleoside transporters: molecular biology and implications for therapeutic development [J].
Baldwin, SA ;
Mackay, JR ;
Cass, CE ;
Young, JD .
MOLECULAR MEDICINE TODAY, 1999, 5 (05) :216-224
[4]  
BALZARINI J, 1993, J BIOL CHEM, V268, P6332
[5]   CRYSTAL-STRUCTURES OF THE THYMIDINE KINASE FROM HERPES-SIMPLEX VIRUS TYPE-I IN COMPLEX WITH DEOXYTHYMIDINE AND GANCICLOVIR [J].
BROWN, DG ;
VISSE, R ;
SANDHU, G ;
DAVIES, A ;
RIZKALLAH, PJ ;
MELITZ, C ;
SUMMERS, WC ;
SANDERSON, MR .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :876-881
[6]   Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes [J].
Cabrita, MA ;
Baldwin, SA ;
Young, JD ;
Cass, CE .
BIOCHEMISTRY AND CELL BIOLOGY, 2002, 80 (05) :623-638
[7]  
Cass C E, 1999, Pharm Biotechnol, V12, P313
[8]  
CHEN MS, 1978, J BIOL CHEM, V253, P1325
[9]   Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant [J].
Chen, SH ;
Cook, WJ ;
Grove, KL ;
Coen, DM .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6710-6715
[10]   Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment [J].
Chen, SH ;
Pearson, A ;
Coen, DM ;
Chen, SH .
JOURNAL OF VIROLOGY, 2004, 78 (01) :520-523